Log in

Start free trial
Signs Point to Expansion of Provider-Initiated Personal Genomic Testing

Signs Point to Expansion of Provider-Initiated Personal Genomic Testing

by | Jun 5, 2017 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

From - Diagnostic Testing & Emerging Technologies
Since 2013 when the U.S. Food and Drug Administration (FDA) effectively stopped direct-to-consumer personal genomic testing, there has been pent up demand among healthy individuals for…


. . . read more

This content is for Paid Members only.
Register
Already a member? Log in here
iSpecimen Generates New Market for Discarded Biospecimens

iSpecimen Generates New Market for Discarded Biospecimens

by | May 2, 2017 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet

From - Diagnostic Testing & Emerging Technologies
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built…


. . . read more

This content is for Paid Members only.
Register
Already a member? Log in here